Ori Biotech Ltd (Ori), an innovator in Cell and Gene Therapy (CGT) manufacturing, announced that they successfully closed a $9.4M (£7M) seed round which will be used to bring their innovative manufacturing platform to market. The syndicate includes leading UK investors Amadeus Capital Partners, Delin Ventures and Kindred Capital.
Amadeus Capital Partners Ltd
Amadeus Capital Partners is a global technology investor. Since 1997, the firm has raised over $1bn for investment and used it to back more than 130 companies. With vast experience and a great network, Amadeus’ team of investors and entrepreneurs share a passion for the transformative power of technology. We invest in consumer services, financial technology, artificial intelligence, cyber security, medical technology, digital healthcare and digital media.